Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy
Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy NIH-sponsored study supports cabotegravir use…
Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy NIH-sponsored study supports cabotegravir use…
Exploratory analysis associates HIV drug abacavir with elevated cardiovascular disease risk in large global trial…
NIH-developed HIV antibodies protect animals in proof-of-concept study Transmission electron micrograph of HIV-1 virus particles…
Long-acting HIV treatment demonstrates efficacy in people with challenges taking daily medicine as prescribed Transmission…
Tools underestimate cardiovascular event risk in people with HIV NIH trial reveals need for more…
Semaglutide reduces severity of common liver disease in people with HIV NIH-funded findings inform interdisciplinary…
Vaginal ring and oral pre-exposure prophylaxis found safe for HIV prevention throughout pregnancy Multi-country findings…
Long-acting HIV treatment benefits adults with barriers to daily pill taking and adolescents with suppressed…
Children surpass a year of HIV remission after treatment pause NIH-funded trial shows promising outcomes…
Novel vaccine concept generates immune responses that could produce multiple types of HIV broadly neutralizing…